Skip to main content
. 2022 Sep 20;117(2):91–101. doi: 10.1093/trstmh/trac091

Table 3.

History of signs and symptoms associated with death and survival (N=1521)

Univariableb Multivariablec
Na Survival N (%) Death N (%) OR 95% CI p aOR 95% CI p
Total 1521 1484 37
Fever duration, median (IQR), d 1509 5 (3–7) 5 (4–7) 0.99 0.91 to 1.07 NS
Symptom duration, median (IQR), d 1453 4 (3–4) 4 (3–4) 1.19 0.84 to 1.68 NS
History of signs and symptoms
 Altered consciousness 1515 62 (4) 21 (57) 30.00 14.91 to 60.26 <0.0001 21.68 8.72 to 53.92 <0.0001
 Bleedingd 1517 32 (2) 7 (19) 10.59 4.33 to 25.89 <0.0001 14.08 4.21 to 47.13 <0.0001
 Oliguria 1515 67 (5) 12 (32) 10.11 4.87 to 21.00 <0.0001 3.41 1.21 to 9.61 0.020
 Breathlessness 1484 190 (13) 17 (47) 5.92 3.03 to 11.60 <0.0001 2.91 1.24 to 6.87 0.015
 Seizures 1514 26 (2) 6 (17) 11.17 4.28 to 29.13 <0.0001 2.13 0.62 to 7.38 NS
 Jaundice 1488 91 (6) 9 (24) 4.80 2.20 to 10.48 <0.0001 1.69 0.61 to 4.70 NS
 Prostration 1507 343 (23) 16 (46) 2.78 1.41 to 5.45 0.003 0.63 0.26 to 1.55 NS
 Vomiting 1492 494 (34) 19 (51) 2.05 1.07 to 3.95 0.031 1.82 0.80 to 4.14 NS
 Nausea 1485 514 (36) 18 (49) 1.72 0.90 to 3.31 NS
 Myalgia 1516 493 (33) 18 (49) 1.90 0.99 to 3.64 NS
 Cough 1518 489 (33) 10 (27) 0.75 0.36 to 1.57 NS
 Sputum 1516 181 (12) 5 (14) 0.82 0.34 to 2.32 NS
 Headache 1517 816 (55) 21 (57) 1.07 0.55 to 2.06 NS
 Retro orbital pain 1514 151 (10) 2 (6) 0.52 0.12 to 2.17 NS
 Abdominal pain 1485 292 (20) 6 (17) 0.79 0.33 to 1.92 NS
 Diarrhea 1486 225 (16) 5 (14) 0.88 0.34 to 2.28 NS
 Arthralgia 1515 210 (14) 6 (16) 1.17 0.48 to 2.84 NS
 Rash 1515 33 (2) 1 (3) 1.22 0.16 to 9.14 NS

Abbreviations: aOR, adjusted odds ratio; NS, not significant.

a

Total number investigated among 1521 patients. Discrepancies due to missing values.

b

Univariable logistic regression.

c

Multivariable logistic regression, age and gender were included.

d

Merged variables “Abnormal bleeding” (N survival and death=19 and 4) and “Blood in stools” (N=16 and 5).

Missing coded as negative in merged variables for the sake of the analyses.